A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis

NCT01363713 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: DE-114 ophthalmic solution

Sponsor

Santen Pharmaceutical Co., Ltd.